# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3991985 | T | Chronic toxicity in female dog assessed as effect on liver weight at 30 mg/kg/day, po administered for 28 days relative to control | Canis lupus familiaris | 1 | ALA3991943 | organism-based format | Patent Bioactivity Data | |
2. | ALA3991986 | T | Chronic toxicity in female dog assessed as effect on heart weight at 100 mg/kg/day, po administered for 28 days relative to body weight | Canis lupus familiaris | 1 | ALA3991943 | organism-based format | Patent Bioactivity Data | |
3. | ALA3991987 | P | Solubility of the compound in PBS buffer at pH 7 | 4 | ALA3991943 | small-molecule physicochemical format | Patent Bioactivity Data | ||
4. | ALA3991988 | P | Solubility of the compound in water by HPLC analysis | 8 | ALA3991943 | small-molecule physicochemical format | Patent Bioactivity Data | ||
5. | ALA3991989 | P | Solubility of the compound in methanol | 1 | ALA3991943 | small-molecule physicochemical format | Patent Bioactivity Data | ||
6. | ALA3991990 | P | Solubility of the compound in ethanol | 1 | ALA3991943 | small-molecule physicochemical format | Patent Bioactivity Data | ||
7. | ALA3991991 | P | Solubility of the compound in benzyl alcohol | 1 | ALA3991943 | small-molecule physicochemical format | Patent Bioactivity Data | ||
8. | ALA3991992 | P | Solubility of the compound in DMSO | 1 | ALA3991943 | small-molecule physicochemical format | Patent Bioactivity Data | ||
9. | ALA3991993 | P | Solubility of the compound in DMF | 1 | ALA3991943 | small-molecule physicochemical format | Patent Bioactivity Data | ||
10. | ALA3991994 | P | Solubility of the compound in propylene glycol | 1 | ALA3991943 | small-molecule physicochemical format | Patent Bioactivity Data | ||
11. | ALA3991995 | P | Solubility of the compound in glycerol | 1 | ALA3991943 | small-molecule physicochemical format | Patent Bioactivity Data | ||
12. | ALA3992001 | B | Inhibition of cKIT D816H mutant (unknown origin) | Homo sapiens | 1 | ALA3991943 | assay format | Patent Bioactivity Data | |
13. | ALA3992002 | B | Inhibition of cKIT D816V mutant (unknown origin) | Homo sapiens | 1 | ALA3991943 | assay format | Patent Bioactivity Data | |
14. | ALA3992003 | B | Inhibition of cKIT V560G mutant (unknown origin) | Homo sapiens | 1 | ALA3991943 | assay format | Patent Bioactivity Data | |
15. | ALA3992004 | B | Inhibition of cKIT V654A mutant (unknown origin) | Homo sapiens | 1 | ALA3991943 | assay format | Patent Bioactivity Data | |
16. | ALA3992005 | B | Inhibition of Flt3 D835Y mutant (unknown origin) | Homo sapiens | 1 | ALA3991943 | assay format | Patent Bioactivity Data | |
17. | ALA3992006 | B | Inhibition of PDGFRalpha D842V mutant (unknown origin) | Homo sapiens | 1 | ALA3991943 | assay format | Patent Bioactivity Data | |
18. | ALA3992007 | B | Inhibition of PDGFRalpha V561D mutant (unknown origin) | Homo sapiens | 1 | ALA3991943 | assay format | Patent Bioactivity Data | |
19. | ALA3992008 | F | Cytotoxicity against human OVCAR3 cells assessed as reduction in cell proliferation | Homo sapiens | 1 | ALA3991943 | cell-based format | Patent Bioactivity Data | |
20. | ALA3992009 | F | Cytostatic activity against human OVCAR3 cells assessed as reduction in cell proliferation | Homo sapiens | 1 | ALA3991943 | cell-based format | Patent Bioactivity Data |